Andere talen Pacific Biosciences of California, Inc.

Aandelen

PACB

US69404D1081

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 21-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1,47 ^USD	-6,37%		-16,48%	-85,02%

10/06	PacBio en het Internationale Consortium Colors kondigen de lancering aan van de allereerste HiFi Long-Read Variant Database	CI
03/06	PACIFIC BIOSCIENCES OF CALIFORNIA, INC. : Jefferies & Co. nog altijd een koopadvies	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

PacBio and International Research Consortium CoLoRS Announce Release of First-Ever HiFi Long-Read Variant Database	10/06
PacBio and International Research Consortium Colors Announce Release of First-Ever HiFi Long-Read Variant Database	10/06
Pacific Biosciences, Ambry Genetics Selected to Sequence up to 7,000 Human Genomes	15/05
Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases	15/05
Ambry Genetics and PacBio Announces Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases	15/05
Pacific Biosciences of California : PacBio Q1 2024 Earnings Presentation	10/05
Pacific Biosciences: Q1 Earnings Snapshot	09/05
Earnings Flash (PACB) PACIFIC BIOSCIENCES OF CALIFORNIA Reports Q1 Revenue $38.8M	09/05
Pacific Biosciences of California, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
PacBio Announces First Quarter 2024 Financial Results	09/05
NewBiologix Launches Next-Generation Sequencing and Optical Mapping Platform to Drive the Next Wave of Biopharmaceutical Discoveries	01/05
Sector Update: Health Care Stocks Higher Late Afternoon	16/04
Sector Update: Health Care	16/04
Pacific Biosciences of California Q1 Revenue Expected to Be Flat Year Over Year; Guidance Lowered; Shares Sink	16/04
PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance	16/04
Pacific Biosciences of California, Inc. Provides Revenue Guidance for the Second Quarter and Full Year 2024	16/04
Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes	27/03
Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes	27/03
PacBio Grants Equity Incentive Award to New Employee	22/03
PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions	12/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Pacific Biosciences of California, Inc.

Aandelen

PACB

US69404D1081

Andere talen

Filters